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UNIT 5.25Overview of Approaches to Preventing
and Avoiding Proteolysis During
Expression and Purification of Proteins
Barry J. Ryan1 and Gary T. Henehan1
1Food Science and Environmental Health, Dublin Institute of Technology, Dublin, Ireland
ABSTRACT
Proteases are enzymes that cleave proteins. They occur widely in nature and serve a fundamental
role in cellular homeostasis; however, their presence can result in unwanted protein degradation
during recombinant protein expression and purification. This unit introduces proteases, specifi-
cally outlining the types commonly encountered during production of recombinant proteins. The
strategies used to avoid and to prevent proteolysis are also highlighted with extensive considera-
tion of the molecular, technical, and logistical methodologies involved. Curr. Protoc. Protein Sci.
71:5.25.1-5.25.7. C© 2013 by John Wiley & Sons, Inc.
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INTRODUCTION
Proteases are a class of enzymes that oc-
cupy a central position with respect to their
physiological roles as well as their impact on
biotechnology. The general reaction catalyzed
by proteases is the degradation (or breakdown)
of proteins. The importance of proteases is il-
lustrated by the fact that they are found in all
forms of living organisms. All cells maintain a
rate of protein turnover by continuous degra-
dation and synthesis of proteins. In addition,
many cells produce extracellular proteases that
break down large proteins into smaller proteins
for absorption (see ?Rao et al., 1998? for re-
view). All these protease activities have the
potential to damage recombinant proteins dur-
ing their expression. In this unit, the strategies
used to avoid and prevent proteolysis during
the expression of recombinant proteins are ex-
amined.
Proteases are members of the hydrolase
family of enzymes (EC: 3.4). This enzyme
family hydrolyzes peptide bonds with the par-
ticipation of a water molecule. Proteases can
be classified based on where this cleavage
takes place. If the cleavage takes place within
the polypeptide backbone, the protease is re-
ferred to as an endoprotease. Examples of en-
doproteases include trypsin and pepsin. Alter-
natively, if the cleavage takes place at the end
of the polypeptide backbone, the protease is
referred to as an exoprotease, with some com-
mon examples being aminopeptidases and car-
boxypeptidases. Proteases have specific cleav-
age sites; for example, trypsin cleaves proteins
at the carboxyl side of the amino acids lysine
and arginine.
The most common recombinant host for
protein production, E. coli, is known to pos-
sess both endo- and exoproteases distributed
throughout the cell (Makrides, 1996; Huang
et al., 2012). Mammalian cells contain com-
partmentalized endo- and exoproteases, which
are vital for a number of cellular processes, in-
cluding protein catabolism and precursor ac-
tivation (Steiner, 2011). The catalytic mecha-
nism is used to further characterize the pro-
tease family. Based on their key functional
active-site residue(s), proteases are broadly
characterized as shown in Table 5.25.1.
Proteolysis is a naturally occurring event
within all cells and is necessary to maintain
homeostasis (King et al., 1996). Proteases con-
trol cellular processes by removing denatured
or misfolded proteins, thus eliminating a po-
tentially dangerous buildup of unwanted pro-
tein material and simultaneously reducing the
requirement for new cellular building blocks
through catabolic “recycling.” The La pro-
tease, a product of the lon gene, is responsible
for hydrolysis of abnormal proteins in E. coli
(Chung and Goldberg, 1981). Other roles for
proteases include their involvement in apopto-
sis (Vandenabeele et al., 2005) and a possible
role as “signaling scissors,” wherein regulated
intramembrane proteolysis controls signaling
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Table 5.25.1 Classification of Protease Families Based on Catalytic Active Site
Type Active-site residues Example
Serine protease Nucleophilic serine Subtilisin (EC 3.4.21.62)
Cysteine protease Nucleophilic cysteine Papain (EC 3.4.22.2)
Aspartic protease Two highly conserved aspartate
residues
Plasmepsin (EC 3.4.23.39)
Metalloproteinase? Catalysis involves a metal, often zinc Adamalysin (EC 3.4.24.46)
in some receptors in the cell membrane (Buck-
ingham, 2003).
In general, proteases are most effective
in their native cellular surroundings, where
they are often compartmentalized into differ-
ent subcellular environments. This physical
separation reduces nonspecific or nonrequired
protease action. Furthermore, protease activity
is regulated within these environments (Vana-
man and Bradshaw, 1999). However, to access
proteins, either native or recombinantly ex-
pressed within the cellular environment, these
cellular compartments must be disrupted or
destroyed. Once these compartments are com-
promised, proteases can also access proteins
from which they are normally physically sep-
arated. This is particularly important during
protein purification. Careful consideration of
the types of proteases present in the cell is
required when attempting to reduce proteoly-
sis during protein expression and subsequent
purification.
STRATEGIES FOR AVOIDING
PROTEOLYSIS
A number of strategies have been described
to prevent proteolysis of proteins, both native
and recombinant, during their expression. The
majority of the examples described below re-
fer to recombinant protein expression in E.
coli, the most widely used host for protein ex-
pression (Samuelson, 2011). Other expression
hosts are available, such as yeast strains, in-
sect cells, and mammalian cells (Demain and
Vaishnav, 2009). These other expression sys-
tems will have their own issues with protease
activity, and similar strategies may be em-
ployed (see Martensen and Justesen, 2001).
These will need to be approached on a case-
by-case basis. A helpful review on protein
expression system choices has been prepared
by an international consortium of researchers
(see Structural Genomics Consortium et al.,
2008).
Use of Protease-Deficient Cells
Probably the simplest method to avoid pro-
teolysis during expression is to use a com-
mercially available protease-deficient host cell
line. E. coli mutant cell lines that have been
genetically engineered to reduce the effect of,
or remove, native E. coli proteases are com-
mercially available. For example, the E. coli
strain BL21 (and its derivatives) is deficient
in two proteases encoded by the lon (cyto-
plasmic protease) and ompT (periplasmic pro-
tease) genes. ?This strain is denoted by the
phenotype lon or ompT, respectively.? The
K12 KS1000 strain is lacking the Prc protease,
which can degrade proteins expressed in the
cytoplasm, while the K12 PR1031 strain is de-
ficient in DnaJ, a chaperone that promotes pro-
tein degradation. The CAG597 and CAG629
strains are deficient in stress-induced proteases
(see Ryan, 2011).
Optimization of Expression
Another simple but effective method to re-
duce protease activity is to manipulate the ex-
pression conditions to achieve a reduction in
the level of misfolded heterologous proteins,
which often has the effect of avoiding proteol-
ysis.
Temperature
One of the easiest parameters to alter is
incubation temperature. Reduction in temper-
ature results in the slower production of re-
combinant protein and can result in improved
protein folding (Baneyx and Mujacic, 2004;
So¨rensen and Mortensen, 2005). Temperature
is known to play a pivotal role in cellular pro-
cessing; for example, some proteases can func-
tion as chaperones (a “helper” protein) at low
temperatures, but act as proteases at elevated
temperatures (Leidhold and Voos, 2007). Spe-
cialized vectors have been developed for ex-
pression of highly sensitive proteins at low
temperatures (Mujacic et al., 1999).
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Induction conditions
The concentration of the inducing reagent
[isopropyl-β-thio-galactoside (IPTG) in the
case of commonly used lac operator–
controlled expression] is another parameter
that can be easily altered to achieve a de-
crease in production of misfolded proteins.
With any optimization protocol, only one vari-
able should be altered in any single experi-
ment, and the effect of changing this parameter
should be assessed over a feasible range on a
small scale. For example, the effect of temper-
ature on recombinant protein production may
be examined by varying the incubation temper-
ature from 20◦C to 37◦C in ∼5◦C increments,
using 10 ml of culture broth. Once one vari-
able has been optimized, keep that variable
constant and repeat the optimization process
with another variable, e.g., concentration of
inducing reagent. The point at which inducer
is added may also be significant. Thus, Gal-
loway and co-workers (2003) have reported
increased protein yield when the induction of
protein expression was initiated in a late-log-
phase culture. ?Also, if induction time runs
for several hours, then periodically checking
protein expression during the induction phase
may indicate a window for production of intact
protein.?
Use of Fusion Constructs
Misfolded proteins may be targets for pro-
teases if they do not form inclusion bodies
(Baneyx and Mujacic, 2004). Fusion of the
expressed protein of choice to a protective
chaperone may offer significant benefit (Terpe,
2003). The oftentimes larger fusion protein
can increase the solubility of the expressed
protein of choice and can provide a “han-
dle” for a single-step purification (Cheng and
Lee, 2010). Examples of commonly used fu-
sion proteins include maltose binding protein
(MBP), N-utilizing substance A (NusA), and
glutathione S-transferase (GST). These can all
be produced by using commercially available
vectors with specialized multiple cloning sites
adjacent to the fusion gene to permit simple
cloning and co-expression. One drawback to
including a fusion protein in an expression and
purification strategy is the requirement to re-
move the fusion protein from the protein of
choice after purification. This, ironically, of-
ten takes the form of a proteolytic step em-
ploying a highly specific, and sometimes ex-
pensive, protease. This cleavage step should
be completed as efficiently as possible and the
protease removed by exhaustive dialysis.
Expressed Protein Targeting
Expressed proteins can be targeted to spe-
cific cellular compartments where they are
less likely to encounter proteases. In E. coli,
the typical example is targeting expression to
the periplasmic space, which has fewer pro-
teases than the cytoplasm. This is particularly
effective for proteins that that require disul-
fide bonds for activity (Baneyx and Mujacic,
2004). The inclusion of a leader sequence 5′ to
the gene of interest, such as the pelB leader, is
used to direct translocation of the recombinant
proteins to the periplasmic space (Barth et al.,
2000). This strategy has resulted in many re-
ports of successful translocation of expressed
proteins (see Mergulha˜o et al., 2005 and ref-
erences within). Because the periplasm con-
tains fewer proteins than the cytoplasm, this
strategy allows the protein of choice to be se-
lectively released from the periplasmic enve-
lope by gentle cell lysis (French et al., 1996).
For some applications, the recombinant pro-
tein may be secreted into the culture medium.
In this way, cell lysis is not required to harvest
the protein of choice and the cellular proteases
are not released (Ni and Chen, 2009). Proteins
secreted into the culture supernatant can be
collected effectively, as outlined by Caldwell
and Lattemann (2004).
Genetic Engineering of Gene
Construct
Proteases often cleave proteins at specific
amino acid sequences. These residues can be
identified by analyzing the gene of the recom-
binant protein for such cleavage sites. If dele-
tion of these sites does not affect the function-
ality of the expressed protein, this strategy may
be used to prevent proteolysis. As mentioned
above in Use of Fusion Constructs, some pu-
rification protocols require the cleavage of a
fusion protein; in these cases, the addition of
specific protease recognition sites between the
fusion protein and the protein of choice is re-
quired. Common examples of these types of
recognition motifs include D-D-D-K for the
enterokinase protease or E-N-L-Y-F-Q-G for
the ?Tobacco Etch Virus? (TEV) protease.
A more radical approach is to randomly
mutate the gene of interest to increase the sta-
bility of the protein of interest. One method
of achieving this is circular permutation; this
involves the fusion of the N- and C-terminal
ends and the production of a new set of ter-
mini at a different location within the pro-
tein (Luger et al., 1989). Whitehead and co-
workers (2009) have used this strategy to
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reduce proteolytic cleavage and hence improve
the half-life of a molecular chaperone from
Methanocaldococcus jannaschii expressed in
E. coli. However, with all such experiments
care must be taken to retain protein function-
ality. Reduced proteolysis, although an impor-
tant goal, cannot overshadow functionality of
the recombinant protein of choice. If this is the
case, an alternative strategy should be imple-
mented to reduce proteolysis.
STRATEGIES FOR PREVENTING
PROTEOLYSIS
In addition to avoiding proteolysis, it is pos-
sible to prevent or minimize the action of pro-
teases by using specific strategies. Some com-
mon strategies used for expression in E. coli
are mentioned elsewhere (see Peti and Page,
2005). The same principles may be extended
to other expression systems.
How Do You Know Whether the
Expressed Protein has Been
Proteolyzed?
It can sometimes be very difficult to deter-
mine whether poor expression is due to prob-
lems with inclusion body formation, expressed
protein toxicity, culture conditions, or prote-
olysis during cell disruption. On occasion, it
may be possible to observe electrophoretic
microheterogeneity of an expressed protein
band, but this is not always detectable. As
a result, measures to reduce proteolysis may
have to be taken in the absence of conclusive
proof that this is an issue. This matter is fur-
ther complicated when proteolysis is a conse-
quence of misfolding due to rapid synthesis,
i.e., only misfolded protein is hydrolyzed (see
Vera et al., 2005). When proteolysis during
expression is suspected, consider undertaking
some of the more common initial measures
outlined above. However, these strategies may
not solve the proteolysis issue, and some fur-
ther strategies aimed at minimizing proteolysis
during cell disruption are outlined below. Of
course, some of these may have drawbacks in
terms of cost or time.
Preventing Proteolysis During Cell
Disruption
As mentioned above, cell disruption is a
critical period when proteases are liberated
from membrane fragments and cellular com-
partments and begin acting on susceptible re-
combinant proteins. Cell disruption typically
involves resuspending cells expressing a re-
combinant protein in a lysis buffer and break-
ing the cells open using sonication, freeze-
thaw cycles, and/or agents such as lysozyme
or detergents (e.g., Triton X-100). It is criti-
cal that this cell lysis stage is carried out in a
way that will minimize protein degradation, as
described below.
When proteolysis is an issue during cell
disruption, the following strategies may serve
to limit proteolytic damage to expressed
proteins:
Keep everything cold
Cell lysis and extraction are best carried out
at low temperatures. Typically, an extraction
buffer is ice cold and lysed cells are kept on
ice until centrifugation. The low temperature
slows the action of proteases.
Work quickly
For the most part, working quickly will
serve to minimize proteolysis. The object is
to purify the protein of interest as quickly as
possible in order to minimize its contact with
a protease. It is important to carry out cell
disruption and subsequent chromatography on
the same day. This avoids a situation in which
the protease is in contact with the expressed
protein for a prolonged period. Rapid purifica-
tion is much easier at a laboratory scale than
at a production scale.
Addition of protease inhibitors
A frequently used strategy is to add protease
inhibitors to the extraction buffer to inhibit
proteases liberated from subcellular compart-
ments. Protease inhibitors are molecules that
block the action of proteases either by cova-
lent modification or by a specific interaction
(Ryan, 2011). There are a number of commer-
cially available protease inhibitors that may be
added at the cell lysis stage either singly or as a
cocktail. It is important that these are added as
close to the time of cell breakage as possible, as
many have short half-lives in solution (see be-
low). Some of these inhibitors act by covalent
modification of active-site residues of specific
proteins. For example, phenylmethanesulfonyl
fluoride (PMSF) reacts with an active-site ser-
ine in serine proteases. Some caution is needed
in its use since it can modify the protein of in-
terest if it has a susceptible serine residue. It
is important to remember that PMSF is unsta-
ble in aqueous solution and needs to be added
to cell lysis buffers immediately prior to use.
Table 5.25.2 lists some examples of commonly
used protease inhibitors.
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Table 5.25.2 Some Examples of Protease Inhibitors Used for the Four Main Classes of
Proteasea
Inhibitor Concentration in lysis buffer Stock solution to prepare
Serine protease inhibitor
AEBSFb 0.1-1.0 mM 100 mM in water; store for 1 month at
−20◦C
PMSF 0.1-1.0 mM 200 mM in isopropanol, freshly prepared.
Add to lysis buffer immediately prior to use
Leupeptin 10-100 μM 10 mM in water; store frozen for up to 6
months
Cysteine protease inhibitor
N-ethylmale-
imide
Equimolar with protease to
be inhibited
10 mg/ml in water, freshly prepared
Antipain 1-100 μM 10 mM in water; store for 1 month at −20◦C
Aspartate protease inhibitor
Pepstatin 1.0 μM 1.0 mM in methanol; store at −20◦C
α 2-macro-
globulin
Equimolar with protease to
be inhibited
Prepare in water; store at −20◦C
Metalloproteinase inhibitor
EDTA 1-10 mM 100 mM in water; store up to 1 year at
−20◦C
Bestatin 1-10 μM 1.0 mM in water; store up to 1 month at
−20◦C
aFurther information can be found in Ryan (2011).
b?4-(2-Aminoethyl)benzenesulfonylfluoride.?
Many of these inhibitors have limited speci-
ficity while others are specific for more than
one class of protease. Trial experiments will
be needed to establish which is appropriate for
a given situation. A convenient starting point,
when proteolysis is suspected, is to use one of
the commercially available protease inhibitor
cocktail mixes.
It is important to note that the list of in-
hibitors in Table 5.25.2 is far from exhaus-
tive and that additional inhibitors are commer-
cially available (Ryan, 2011). A database of
proteases and their inhibitors has been estab-
lished that can be a useful source of reference
(Rawlings et al., 2012).
Preventing Proteolysis of Proteins
During Purification
In general, proteolysis of proteins during
purification of recombinant proteins is not a
problem if steps have been taken to inactivate
proteases at the cell lysis stage. On occasion,
however, proteases may be carried over with
a purified protein. This may be observed as
gradual protein degradation during storage and
can be addressed by further purification or by
re-application of specific protease inhibitors.
The former is always preferable and a variety
of chromatographic methods may need to be
investigated (see Chapters 8 and 9).
It is important to be sure that loss of ac-
tivity during purification is not due to causes
other than proteolysis. There are a finite num-
ber of reasons for loss of activity or function
of a protein during purification, ?and these are
described below.?
Oxidation
Proteins that require a reduced thiol (on a
cysteine residue, for example) for activity or
function may become oxidized during purifi-
cation. Thiols can be maintained in a reduced
state by addition of β-mercaptoethanol or DTT
(1 to 2 mM).
Loss of cofactor or activating metal ion
Some proteins require a cofactor or a metal
ion for proper function. This can be lost during
purification. Buffers containing EDTA (used
for inhibition of metalloproteinases) are often
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a culprit since the EDTA can chelate metal
ions. The solution is to exchange into a buffer
lacking EDTA but containing the appropriate
metal ion or cofactor.
Inactivation by buffer components
Some buffer salts may inactivate certain en-
zymes. The solution is to exchange into a dif-
ferent buffer.
Inhibition by metal ions
Certain divalent cations may interact with
protein thiols to cause inactivation. EDTA is
often added at a concentration of 2.0 mM to
prevent this inactivation.
All of these patterns of inactivation may
be mistaken for proteolysis, thus causing in-
appropriate action to be taken. Therefore, it is
essential to eliminate these causes before con-
sidering proteolysis in the absence of specific
evidence (see Simpson, 2010 for a review of
protein stability).
SPECIAL PROBLEM OF
EXPRESSION OF PROTEIN
FRAGMENTS
A particular problem may arise when an at-
tempt is made to express a truncated protein or
a particular domain of a protein that may not
be an issue when expressing the full-length
protein. According to some studies, this may
be overcome by extending the ends by up to
20 amino acids (see So¨rensen and Mortensen,
2005). This issue has been studied in detail
by several groups, and systematic approaches
to preventing proteolysis by terminal modifi-
cations have been reported (Bowie and Sauer,
1989; Structural Genomics Consortium et al.,
2008).
SUMMARY
Proteolysis can occur at many stages dur-
ing the production and purification of a re-
combinant protein. If protein degradation is
suspected at any stage, it is crucial to exam-
ine the expression and purification protocols
to ensure that true proteolysis has occurred.
If proteolysis has been confirmed, alternative
methods can be used during expression, cel-
lular disruption, and purification to minimize
protein degradation. It may be helpful to iden-
tify the type of protease involved in order to
design a customized protocol to avoid prote-
olysis. However, investigation of the type of
protease is an empirical process and must be
carried for each individual protein. In all cases
it is a better strategy to avoid proteolysis alto-
gether than to have to prevent it after cell lysis
and purification.
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